0.74 USD
▼+0.03-5.11%
盘后 0.78 +0.13%
2026-08-03
市值
$13.81M
市盈率
—
EPS
-6.34
股息率
—
52 周区间
0.59 – 1,030.00
成交量
127.61K
Beta
-2.36
目标价
—
52W 低 0.5952W 高 1,030.00
价格走势
公司简介
KALA BIO, Inc., a biopharmaceutical company, engages in the development of an on-premises artificial intelligence (AI) infrastructure platform for biotechnology research applications in the United States. The company develops Researgency, an agentic AI research platform for private enterprise AI deployment. Its platform intends to utilize the KPI-012 clinical development dataset as a proof-of-concept validation environment, as well as the mesenchymal stem cell secretome (MSC-S) and persistent corneal epithelial defects (PCED) research for agent...